Overall cohort (N = 2599) | |
---|---|
Age (years, median, IQR) | 61 (51–72) |
Gender | |
Female | 1328 (51.9%) |
Male | 1231 (48.1%) |
Race | |
Black | 233 (9.1%) |
Other | 122 (4.8%) |
White | 2204 (86.1%) |
Income | |
Below median | 733 (28.6%) |
Above median | 1763 (68.9%) |
Insurance status | |
None | 69 (2.7%) |
Private/government | 2300 (89.9%) |
Annual hospital volume (cases, median, IQR) | 3 (1–10) |
Travel distance (miles, median, IQR) | 14 (4–63) |
Charlson-Deyo score | |
0 | 1475 (57.6%) |
1 | 319 (12.5%) |
≥ 2 | 77 (3.0%) |
Tumor grade | |
1 | 742 (29%) |
2 | 318 (12.4%) |
3 | 1057 (41.3%) |
Neoadjuvant therapy | 73 (2.9%) |
Extent of surgery | |
Local | 757 (29.6%) |
Radical | 1011 (39.5%) |
Simple | 791 (30.9%) |
Appropriateness of resection | |
R2 | 89 (3.5%) |
R0/1 | 1722 (67.3%) |
Hospital length of stay (days, median, IQR) | 6 (3–8) |
Radiotherapy | 689 (26.9%) |
30-day mortality | 95 (3.7%) |
30-day readmission | 95 (3.7%) |